These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30412443)

  • 1. Central artery stiffness and thoracic aortopathy.
    Humphrey JD; Tellides G
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H169-H182. PubMed ID: 30412443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and sex-specific biomechanics and extracellular matrix remodeling of the ascending aorta in a mouse model of severe Marfan syndrome.
    Dwivedi KK; Rother J; Wagenseil JE
    Am J Physiol Heart Circ Physiol; 2024 Oct; 327(4):H1037-H1051. PubMed ID: 39212766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.
    Humphrey JD; Schwartz MA; Tellides G; Milewicz DM
    Circ Res; 2015 Apr; 116(8):1448-61. PubMed ID: 25858068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1
    Chen JZ; Sawada H; Ye D; Katsumata Y; Kukida M; Ohno-Urabe S; Moorleghen JJ; Franklin MK; Howatt DA; Sheppard MB; Mullick AE; Lu HS; Daugherty A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2538-2550. PubMed ID: 34407634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome.
    Dale M; Fitzgerald MP; Liu Z; Meisinger T; Karpisek A; Purcell LN; Carson JS; Harding P; Lang H; Koutakis P; Suh M; Batra R; Mietus CJ; Casale G; Pipinos I; Baxter BT; Xiong W
    PLoS One; 2017; 12(10):e0186603. PubMed ID: 29040313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.
    Gharraee N; Sun Y; Swisher JA; Lessner SM
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H44-H56. PubMed ID: 34714692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of thoracic spine deformity and cardiovascular disease in a mouse model for Marfan syndrome.
    de Souza RB; Farinha-Arcieri LE; Catroxo MHB; Martins AMCRPDF; Tedesco RC; Alonso LG; Koh IHJ; Pereira LV
    PLoS One; 2019; 14(11):e0224581. PubMed ID: 31725753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome.
    Bellini C; Korneva A; Zilberberg L; Ramirez F; Rifkin DB; Humphrey JD
    J Biomech; 2016 Aug; 49(12):2383-2389. PubMed ID: 26755343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms.
    Gomez D; Coyet A; Ollivier V; Jeunemaitre X; Jondeau G; Michel JB; Vranckx R
    Cardiovasc Res; 2011 Feb; 89(2):446-56. PubMed ID: 20829218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific miRNA and Gene Deregulation Characterize the Increased Angiogenic Remodeling of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome.
    D'Amico F; Doldo E; Pisano C; Scioli MG; Centofanti F; Proietti G; Falconi M; Sangiuolo F; Ferlosio A; Ruvolo G; Orlandi A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Microvascular Tone and Extracellular Matrix Contraction in the Regulation of Interstitial Fluid: Implications for Aortic Dissection.
    Mallat Z; Tedgui A; Henrion D
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1742-7. PubMed ID: 27444198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis on aortic smooth muscle cells reveals new potential targets for the treatment of Marfan syndrome-associated thoracic aortic aneurysm.
    Rega S; Bouhuis S; Vescio M; Gaspardo A; Munno M; Pattini L; Banfi C; Pompilio G; Perrucci GL
    Vascul Pharmacol; 2024 Jun; 155():107341. PubMed ID: 38985619
    [No Abstract]   [Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.
    Jones JA; Spinale FG; Ikonomidis JS
    J Vasc Res; 2009; 46(2):119-37. PubMed ID: 18765947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical knockouts-In silico assessment of factors predisposing to thoracic aortic aneurysms.
    Latorre M; Humphrey JD
    PLoS Comput Biol; 2020 Oct; 16(10):e1008273. PubMed ID: 33079926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms of thoracic aortic aneurysms.
    El-Hamamsy I; Yacoub MH
    Nat Rev Cardiol; 2009 Dec; 6(12):771-86. PubMed ID: 19884902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myh11(R247C/R247C) mutations increase thoracic aorta vulnerability to intramural damage despite a general biomechanical adaptivity.
    Bellini C; Wang S; Milewicz DM; Humphrey JD
    J Biomech; 2015 Jan; 48(1):113-21. PubMed ID: 25433566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.